Prenatal Magnesium Sulfate Exposure and Risk of Cerebral Palsy

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 13, 1997, Pages 1033-

  Allred, Elizabeth N ^a   Dammann, Olaf ^a   Kuban, Karl K C ^a   Leviton, Alan ^a   Pagano, Marcello ^a   Stewart, Jane E ^a   Vanmarter, Linda J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ADULT; CEREBRAL PALSY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; TOCOLYSIS; TREATMENT INDICATION; VERY LOW BIRTH WEIGHT;

EID: 0031003776     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540370023015     Document Type: Letter

References (6)

1. Schendel DE, Berg CJ, Yeargin-Alsopp M, Boyle, CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 1996;276:1805-1810.
2. Kuban KCK, Leviton A, Pagano M, et al. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 1992;7:70-76.
3. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995;346:1449-1954.
4. Grether JK, Nelson KB, Emery ES, Cummins SK. Prenatal and perinatal factor and cerebral palsy in very low birth weight infants. J Pediatr. 1996;128:407-414.
5. Murphy DJ, Johnson A. Placental infection and risk of cerebral palsy in very low birth weight infants. J Pediatr. 1996;129:776-777.
6. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 1995;263-269.